Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥51.4bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥72.0bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥36.2bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥19.6bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥5.5bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥19.8bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥10.0bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥5.7bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥19.2bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥5.7bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥14.3bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥8.0bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥4.1bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥14.3bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥4.1bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥187.1bnat 2024-09-30Cons.Assets
Total assets¥171.6bnat 2024-03-31Cons.Assets
Total assets¥171.7bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥32.7bnat 2024-09-30Cons.Liabilities
Total liabilities¥27.9bnat 2024-03-31Cons.Liabilities
Net assets / equity¥154.4bnat 2024-09-30Cons.Net assets
Net assets / equity¥143.8bnat 2024-03-31Cons.Net assets
Net assets / equity¥140.7bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥67.3bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥50.6bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥84.0bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥65.3bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥70.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥74.3bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥23.9bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.6bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥245m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥2.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥5.9bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.1bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥2.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥5.7bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥2.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥377.232024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥212.672023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥108.182023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio82.5%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio83.8%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio82.0%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue2024-04-01 → 2024-09-30¥50.1bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue external2024-04-01 → 2024-09-30¥50.1bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentsegment profit2024-04-01 → 2024-09-30¥18.9bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue2024-04-01 → 2024-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue external2024-04-01 → 2024-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentsegment profit2024-04-01 → 2024-09-30¥676m
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥51.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥51.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥19.6bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue2023-04-01 → 2023-09-30¥35.0bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentrevenue external2023-04-01 → 2023-09-30¥35.0bn
jpcrp040300-q2r_E00935-000Medicinereportable segmentsegment profit2023-04-01 → 2023-09-30¥4.9bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentrevenue external2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E00935-000Real Estatereportable segmentsegment profit2023-04-01 → 2023-09-30¥661m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥36.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥36.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥5.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 490
ItemContextValueUnit
Amortization of goodwill ope cfPrior1YTDDuration117000000JPY
Amortization of goodwill ope cfCurrentYTDDuration39000000JPY
Increase decrease in retirement benefit asset and liability ope cfPrior1YTDDuration-87000000JPY
Increase decrease in retirement benefit asset and liability ope cfCurrentYTDDuration-279000000JPY
Interest and dividends income ope cfPrior1YTDDuration-255000000JPY
Interest and dividends income ope cfCurrentYTDDuration-303000000JPY
Interest expenses ope cfPrior1YTDDuration8000000JPY
Interest expenses ope cfCurrentYTDDuration12000000JPY
Loss gain on investments in partnership ope cfPrior1YTDDuration2000000JPY
Loss gain on investments in partnership ope cfCurrentYTDDuration16000000JPY
Loss gain on sales of investment securities ope cfPrior1YTDDuration-4000000JPY
Loss gain on sales of investment securities ope cfCurrentYTDDuration-JPY
Loss gain on valuation of investment securities ope cfPrior1YTDDuration-JPY
Loss gain on valuation of investment securities ope cfCurrentYTDDuration546000000JPY
Loss on retirement of property plant and equipment ope cfPrior1YTDDuration69000000JPY
Loss on retirement of property plant and equipment ope cfCurrentYTDDuration41000000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration-4870000000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration2692000000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-2293000000JPY
Decrease increase in inventories ope cfCurrentYTDDuration304000000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration2034000000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-1082000000JPY
Other net ope cfPrior1YTDDuration-392000000JPY
Other net ope cfCurrentYTDDuration1110000000JPY
Subtotal ope cfPrior1YTDDuration1278000000JPY
Subtotal ope cfCurrentYTDDuration23600000000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration255000000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration301000000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration-8000000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration-12000000JPY
Income taxes paid refund ope cfPrior1YTDDuration-1769000000JPY
Income taxes paid refund ope cfCurrentYTDDuration43000000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration-245000000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration23932000000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration-734000000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-1961000000JPY
Purchase of intangible assets inv cfPrior1YTDDuration-186000000JPY
Purchase of intangible assets inv cfCurrentYTDDuration-61000000JPY
Purchase of investment securities inv cfPrior1YTDDuration-JPY
Purchase of investment securities inv cfCurrentYTDDuration-200000000JPY
Proceeds from sales of investment securities inv cfPrior1YTDDuration8000000JPY
Proceeds from sales of investment securities inv cfCurrentYTDDuration-JPY
Other net inv cfPrior1YTDDuration-228000000JPY
Other net inv cfCurrentYTDDuration-209000000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-1141000000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-2432000000JPY
Net decrease increase in treasury stock fin cfPrior1YTDDuration0JPY
Net decrease increase in treasury stock fin cfCurrentYTDDuration1000000JPY
Cash dividends paid fin cfPrior1YTDDuration-2813000000JPY
Cash dividends paid fin cfCurrentYTDDuration-2840000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass